http://dbpedia.org/ontology/abstract
|
CBS-0550 is a drug developed by Taisho Pha … CBS-0550 is a drug developed by Taisho Pharmaceutical, which acts as a potent and selective cannabinoid CB2 receptor agonist, with 1400x selectivity for CB2 over the related CB1 receptor. Unlike most cannabinoid agonists, CBS-0550 has good solubility in water, and in animal studies it was found to produce analgesic and anti-hyperalgesic effects. A number of related compounds have been developed with similar properties.ve been developed with similar properties.
|
http://dbpedia.org/ontology/casNumber
|
887289-02-3
|
http://dbpedia.org/ontology/fdaUniiCode
|
TB180WQ919
|
http://dbpedia.org/ontology/pubchem
|
24763642
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/CBS-0550.svg?width=300 +
|
http://dbpedia.org/ontology/wikiPageID
|
35446279
|
http://dbpedia.org/ontology/wikiPageLength
|
2638
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1083017936
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Cyclopropanes +
, http://dbpedia.org/resource/Category:Trifluoromethyl_compounds +
, http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/Analgesic +
, http://dbpedia.org/resource/Receptor_%28biochemistry%29 +
, http://dbpedia.org/resource/Cannabinoid +
, http://dbpedia.org/resource/Taisho_Pharmaceutical +
, http://dbpedia.org/resource/Cannabinoid_receptor_1 +
, http://dbpedia.org/resource/Category:Tert-butyl_compounds +
, http://dbpedia.org/resource/Agonist +
, http://dbpedia.org/resource/Hyperalgesia +
, http://dbpedia.org/resource/Category:Cannabinoids +
, http://dbpedia.org/resource/Cannabinoid_receptor_2 +
, http://dbpedia.org/resource/A-836%2C339 +
, http://dbpedia.org/resource/Category:Pyrazoles +
, http://dbpedia.org/resource/SER-601 +
|
http://dbpedia.org/property/c
|
20
|
http://dbpedia.org/property/casNumber
|
887289
|
http://dbpedia.org/property/chemspiderid
|
23320245
|
http://dbpedia.org/property/f
|
4
|
http://dbpedia.org/property/h
|
23
|
http://dbpedia.org/property/iupacName
|
N-[5-tert-butyl-2--1-methylpyrazol-3-ylidene]-2-fluoro-3-benzamide
|
http://dbpedia.org/property/n
|
3
|
http://dbpedia.org/property/o
|
1
|
http://dbpedia.org/property/pubchem
|
24763642
|
http://dbpedia.org/property/smiles
|
C3CC3Cn1c=N\Cc2ccccc2F
|
http://dbpedia.org/property/stdinchi
|
1
|
http://dbpedia.org/property/stdinchikey
|
PABOWKPYVAFTRN-PCLIKHOPSA-N
|
http://dbpedia.org/property/unii
|
TB180WQ919
|
http://dbpedia.org/property/width
|
200
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Cannabinoid-stub +
, http://dbpedia.org/resource/Template:Cannabinoids +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Cyclopropanes +
, http://dbpedia.org/resource/Category:Cannabinoids +
, http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/Category:Tert-butyl_compounds +
, http://dbpedia.org/resource/Category:Pyrazoles +
, http://dbpedia.org/resource/Category:Trifluoromethyl_compounds +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/CBS-0550?oldid=1083017936&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/CBS-0550.svg +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/CBS-0550 +
|
owl:sameAs |
http://dbpedia.org/resource/CBS-0550 +
, http://rdf.freebase.com/ns/m.0j9q6yg +
, https://global.dbpedia.org/id/4e532 +
, http://sr.dbpedia.org/resource/CBS-0550 +
, http://www.wikidata.org/entity/Q5009205 +
, http://sh.dbpedia.org/resource/CBS-0550 +
|
rdf:type |
http://dbpedia.org/ontology/Drug +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/ChemicalSubstance +
|
rdfs:comment |
CBS-0550 is a drug developed by Taisho Pha … CBS-0550 is a drug developed by Taisho Pharmaceutical, which acts as a potent and selective cannabinoid CB2 receptor agonist, with 1400x selectivity for CB2 over the related CB1 receptor. Unlike most cannabinoid agonists, CBS-0550 has good solubility in water, and in animal studies it was found to produce analgesic and anti-hyperalgesic effects. A number of related compounds have been developed with similar properties.ve been developed with similar properties.
|
rdfs:label |
CBS-0550
|